Restart of Anticoagulant Therapy and Risk of Thrombosis, Rebleeding, and Death after Factor Xa Inhibitor Reversal in Major Bleeding Patients

Background  Lack of data on balancing bleeding and thrombosis risk causes uncertainty about restarting anticoagulants after major bleeding. Anticoagulant reversal trials offer prospectively gathered data after major bleeding with well-documented safety events and restarting behavior. Objectives  To...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Thromb Haemost
Main Authors: Milling, Truman J., King, Ben, Yue, Patrick, Middeldorp, Saskia, Beyer-Westendorf, Jan, Eikelboom, John W., Crowther, Mark, Xu, Lizhen, Verhamme, Peter, Siegal, Deborah M., Connolly, Stuart J.
Format: Artigo
Sprog:Inglês
Udgivet: Georg Thieme Verlag KG 2021
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8322590/
https://ncbi.nlm.nih.gov/pubmed/33634446
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/a-1400-6159
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker